Skip to main content
About
Our Strategy
Our Leadership
Our Board of Directors
Stories
Improving Care and Treatment Outcomes
Moving together to create impact
Breaking the Silence for Change
Science
Science and Technology
Antibody and T-cell Engager Platform
PRO-XTEN
®
Masking Platform
Literature Archive
Pipeline
Our Pipeline
Our Therapeutic Focus
Our Collaborators
Careers
Job Opportunities
Contact
Investors
News
Events & Presentations
Stock Info
Stock Quote
Analyst Coverage
Financials
Quarterly Reports
SEC Filings
Governance
Governance Documents
Committee Composition
Whistleblower Hotline
Resources
Investor FAQs
Information Request Form
Investor Email Alerts
Investor Contact
Powering the Immune System
to Transform Lives
Our Board of Directors
Jeffrey S. Hatfield, MBA
Chair of the Board
Marianne De Backer,
M.Sc., Ph.D., MBA
PRESIDENT, CHIEF EXECUTIVE OFFICER AND DIRECTOR
Norbert Bischofberger, Ph.D.
Director
Timothy Coughlin, CPA
Director
Ramy Farid, Ph.D.
Director
Robert More, MBA
Director
Janet Napolitano, J.D.
Director
Elliott Sigal, M.D., Ph.D.
Director
